Sector consensus Kymera Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 18/05/2026 BST			5-day change	1st Jan Change
79.67 ^USD	-3.09%		-5.27%	+2.39%

05-15	Kymera Therapeutics announces presentations on KT-621, a first-in-class, oral Stat6 degrader, at the Society for Investigative Dermatology and American Thoracic Society congresses	RE
05-12	Kymera Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09:20 AM

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
KYMERA THERAPEUTICS, INC.	118.27	+43.87%	22
LONZA GROUP AG	669.3	+42.59%	23
BEONE MEDICINES AG	411.38	+40.27%	27
REVOLUTION MEDICINES, INC.	181.3	+24.47%	20
IQVIA HOLDINGS INC.	228.6	+35.17%	20
CELLTRION, INC.	262,833.33	+39.21%	24
IONIS PHARMACEUTICALS, INC.	100.78	+35.77%	23
EUROFINS SCIENTIFIC SE	70.74	+19.34%	14
MEDPACE HOLDINGS, INC.	442.83	+6.64%	12
PRAXIS PRECISION MEDICINES, INC.	652.18	+90.37%	17
ABIVAX	121.48	+22.65%	7
ICON PUBLIC LIMITED COMPANY	133.29	+14.53%	14
TEMPUS AI, INC.	67.2	+52.97%	15
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	208.8	+38.42%	15
BACHEM HOLDING AG	78.8	+4.58%	10
QIAGEN N.V.	43.82	+32.87%	14
BIO-TECHNE CORPORATION	61.42	+41.84%	12
PHARMARON BEIJING CO., LTD.	37.26	+40.12%	12
Average	14,803.38	+34.76%	17
Weighted average by Cap.	25,698.19	+35.25%	19